Board Of Directors

WORK EXPERIENCE

Mr. Ho is the Executive Chairman of Keck Seng (Malaysia) Berhad since 1970 and also of Keck Seng Investments (Hong Kong) Limited since 1979. He was previously a Non-Executive Director of Shangri-la Asia Limited since 1993 and a member of its Audit Committee. He was previously the Director of Parkway Holdings Limited/Parkway Pantai Limited from 1985 to 2013 and was the Chairman of the Tender Committee.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Business Administration and Commerce

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Executive Chairman of Keck Seng Investments (Hong Kong) Limited
• Executive Chairman of Keck Seng (Malaysia) Berhad

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Non-Executive Director of Shangri-la Asia Limited

WORK EXPERIENCE

Ms. Cheah serves as Executive Board Chair of privately held ESG startup ecoSPIRITS and sits on the boards of several publicly-listed companies in Singapore. She is also Venture Partner at Wavemaker Partners, a tech-focused venture capital fund dual headquartered in Singapore and Los Angeles.

She previously spent more than 20 years in the investment banking industry. She started her career with Merrill Lynch New York, followed by stints in Singapore and London. Subsequently, she became Executive Director of Investment Banking at JP Morgan Singapore and later served as Co-head of Corporate Finance SEA at BNP Paribas.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• BA, Economics and French, Wellesley College, Massachusetts, USA
• Executive MBA (ongoing), Tsinghua University, PRC

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Executive Board Chair, ecoSPIRITS Pte Ltd
• Independent Non-Executive Director of Pathology Asia Holdings Pte Ltd (also Chairman of Audit Committee)
• Independent Non-Executive Director of TeleChoice International Limited (also Member of Audit Committee)
• Independent Non-Executive Director of M&C REIT Management Limited (also Member of Nominating and Remuneration Committee)
• Independent Non-Executive Director of M&C Business Trust Management Limited
• Venture Partner of Wavemaker Partners

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Nil

WORK EXPERIENCE

Ms Goh is the Founding Director of 360 Dynamics since 1998. It is a boutique firm which provides consulting services to businesses on their organisational design and developmental needs. She guides corporate leaders to be more effective through an innate understanding of Organizational and leadership Dynamics. Her work covers the broader context of achieving business and societal objectives in an interconnected ecosystem that faces rapid changes. She was a Board member of the Agency for Integrated Care from 2012 to 2024.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• MSC, Organisational Psychology, City University of New York (Baruch College)
• BBA, National University of Singapore
• Senior Accredited Director, Singapore Institute of Directors

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Board Member of Parkway Trust Management Limited
• Appointed Chairperson of Charity Council, Singapore

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Chairperson of SATA CommHealth Limited

WORK EXPERIENCE

Dato’ Sri Muthanna Abdullah is a Barrister of Middle Temple and an Advocate and Solicitor of the High Court of Malaya. He read law at the University of Buckingham, England and was called to the Bar of England and Wales in 1982 and to the Malaysian Bar in 1983. He is a Consultant of Abdullah Chan & Co.

Dato’ Sri Muthanna was appointed as the Honorary Consul to Kuala Lumpur of the Republic of San Marino on 30 March 2017.

He is also a Director of IHH Healthcare Berhad, MSM Malaysia Holdings Berhad, MSIG Insurance Malaysia Berhad, Malaysian Life Reinsurance Group Berhad, Kuala Lumpur Business Club and a Trustee of The Habitat Foundation and Yayasan Siti Sapura.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Bachelor of Law, University of Buckingham, England
• Barrister-at-Law, Honourable Society of Middle Temple (England)

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Independent Non-Executive Director of Malaysian Life Reinsurance Group Berhad
• Independent Non-Executive Director of MSM Malaysia Holdings Berhad
• Chairman, Independent Non-Executive Director of MSIG Insurance (Malaysia) Bhd
• Independent Non-Executive Director of IHH Healthcare Berhad

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Independent Non-Executive Director of Sapura Resources Berhad
• Independent Non-Executive Director of Digital Nasional Berhad
• Independent Non-Executive Director of KPJ Healthcare Berhad
• Independent Non-Executive Director of Malaysia Rating Corporation Berhad

WORK EXPERIENCE

Dr. Prem Kumar Nair was appointed Group Chief Executive Officer of IHH Healthcare on 1 October 2023, where he leads a team of more than 65,000 employees to realise IHH’s vision to be the world’s most trusted healthcare services network.

Dr. Nair sets the strategic direction for the sustainable growth of IHH’s global network which today comprises more than 80 hospitals in 10 countries. Guided by its Care. For Good. aspiration, Dr. Nair continues to build on the IHH portfolio of strong and reputable brands including Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway - to touch lives and transform care globally.

Prior to his Group CEO appointment, he was CEO of IHH Singapore, where he oversaw the operations and management of IHH’s business units in the country and played an instrumental role in its strategic business growth and outreach efforts in overseas markets.

Dr. Nair is a physician and healthcare executive with over three decades of experience in both public and private healthcare sectors. He was with Raffles Medical Group for 27 years, where he held concurrent roles as Chief Corporate Officer, and Managing Director for Singapore Healthcare. He is an Adjunct Associate Professor at the National University of Singapore’s Saw Swee Hock School of Public Health.

An active community citizen, Dr. Nair was a recipient of the Public Service Medal (Pingat Bakti Masyarakat) and the Public Service Star (Bintang Bakti Masyarakat) at the 2010 and 2022 National Day Awards respectively, for his contributions to the Singapore Prison Service. He is also a Justice of the Peace.

Dr. Nair graduated from the National University of Singapore with a Bachelor of Medicine & Surgery, and a Master of Business Administration (Distinction) from Alliance Manchester Business School.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Bachelor of Medicine & Bachelor of Surgery (MBBS) - National University of Singapore
• Master of Business Administration (Distinction) - Manchester Business School, United Kingdom

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Group Chief Executive Officer, IHH Healthcare Berhad
• Director of Gleneagles Medical Holdings Limited
• Director of Mount Elizabeth Medical Holdings Ltd
• Director of M & P Investments Pte Ltd
• Director of Medi-Rad Associates Ltd
• Director of Parkway Promotions Pte Ltd
• Director of Parkway Laboratory Services Ltd
• Director of Gleneagles Medical Centre Ltd
• Director of Radiology Consultants Pte Ltd
• Director of Shenton Family Medical Clinics Pte Ltd
• Director of Gleneagles Development Pte Ltd
• Director of Gleneagles Pharmacy Pte Ltd
• Director of iXchange Pte Ltd
• Director of Medical Resources International Pte Ltd
• Director of Parkway Shenton Pte Ltd
• Director of Nippon Medical Care Pte Ltd
• Director of Parkway Shenton International Holdings Pte Ltd
• Director of Parkway Hospitals Singapore Pte Ltd
• Director of NorthLight School
• Director of Parkway Investments Pte Ltd
• Director of Parkway College of Nursing & Allied Health Pte Ltd
• Director of Parkway Novena Pte Ltd
• Director of Parkway Irrawaddy Pte Ltd
• Director of Gleneagles JPMC Sdn Bhd
• Director of Gleneagles Management Services Pte Ltd
• Director of Parkway Pantai Limited
• Director of Parkway Holdings Limited
• Director of Parkway Group Healthcare Pte Ltd
• Director of PCH Holding Pte Ltd
• Director of GHK Hospital Limited
• Director of Parkway HK Holdings Limited
• Director of Parkway Medical Services (Hong Kong) Limited
• Director of IHH Financial Services Pte Ltd
• Director of Northern TK Venture Pte Ltd

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Chief Executive Officer, Singapore of IHH Healthcare Berhad

WORK EXPERIENCE

Mr. Tomo Nagahiro was appointed to the Board of IHH in February 2023. Mr. Nagahiro was an alternate director on the Board of IHH from April 2019 to January 2023.

Mr. Nagahiro has been General Manager of Healthcare Services & Data Business Department in Wellness Business Unit of Mitsui & Co., Ltd (Mitsui), overseeing Mitsui’s investment in IHH since April 2019.

He has over 20 years of working experience having served in multiple divisions in Mitsui, spanning from strategic planning, business development and operations management. Preceding his current appointment, he was seconded to MIMS Pte Ltd which is based in Singapore as the Chief Operating Officer from 2015 to 2018.

Prior to this, he was seconded to Parkway Pantai Limited, a wholly-owned subsidiary of IHH, as Assistant Vice President of Strategic Planning and Business Development where he led multiple business development projects from 2013 to 2015.

Mr. Nagahiro holds a Bachelor of Arts in Law from University of Tokyo, Japan; Master of Business Administration from Kellogg School of Management, Northwestern University and is U.S. Certified Public Accountant.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Bachelor of Arts in Law (concentration in Administration Law), The University of Tokyo, Japan
• U.S. Certified Public Accountant – State of Delaware, U.S.A.
• Master of Business Administration, Kellogg School of Management, Northwestern University, U.S.A.

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Chief Executive Officer and Director of MBK Healthcare Management Pte. Ltd.
• Non-Executive Director of IHH Healthcare Berhad
• Non-Executive Director of Fortis Healthcare Limited
• Non-Executive Director of Tomopiia Co., Ltd.

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• General Manager of Strategic Planning Department (Wellness Business Unit), Mitsui & Co., Ltd
• General Manager of Healthcare Services & Data Business Department (Wellness Business Unit), Mitsui & Co., Ltd

WORK EXPERIENCE

As the Acting Chief Executive Officer of IHH Singapore from 1 October 2023, Dr. Peter Chow oversees the operations and management of IHH’s business units in Singapore, which includes Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East hospitals, primary healthcare group Parkway Shenton, Parkway MediCentre, as well as ancillary and education entities such as Parkway Radiology, Parkway Rehab, Parkway Cancer Centre and Parkway College.

Dr. Chow joined IHH in 2018 and was appointed as Chief Executive Officer of Mount Elizabeth Novena Hospital in 2020. Despite challenges from the Covid-19 pandemic, he led the hospital through a period of strategic development and growth, strengthening its position as a regional centre of clinical excellence. In 2022, he was awarded the Public Service Medal (Covid-19) for his healthcare leadership role during the pandemic and for supporting various national pandemic efforts in Singapore.

Dr. Chow has over 20 years of healthcare management experience spanning both public and private sectors in Singapore. Trained as a dental surgeon with the National University of Singapore, he started his career as a dental officer. Subsequently he took on different management roles including quality, training, manpower, as well as managed outpatient clinical services, giving him broad-based experience in healthcare.

Prior to IHH, he was with National Healthcare Group (NHG) during which he assumed various roles including Director of Quality & College, Director of Corporate Development & Communications and Chief Operating Officer of NHG Polyclinics.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Bachelor of Dental Surgery – National University of Singapore
• Master of Health Science (Management) – University of Sydney, Australia

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Acting Chief Executive Officer, IHH Healthcare Singapore
• Director of Gleneagles Pharmacy Pte Ltd
• Director of Gleneagles JPMC Sdn Bhd
• Director of Parkway Hospitals Singapore Pte Ltd
• Director of Mount Elizabeth Medical Holdings Ltd
• Director of Medi-Rad Associates Ltd
• Director of Parkway Promotions Pte Ltd
• Director of Gleneagles Medical Centre Ltd
• Director of Radiology Consultants Pte Ltd
• Director of Shenton Family Medical Clinics Pte Ltd
• Director of iXchange Pte Ltd
• Director of Parkway Shenton Pte Ltd
• Director of Nippon Medical Care Pte Ltd
• Director of Parkway Shenton International Holdings Pte Ltd
• Director of Parkway Investments Pte Ltd
• Director of Parkway College of Nursing & Allied Health Pte Ltd
• Director of Parkway Novena Pte Ltd
• Director of Parkway Irrawaddy Pte Ltd

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Chief Executive Officer, Mount Elizabeth Novena Hospital

WORK EXPERIENCE

Mr. Yong is the CEO and Executive Director of Parkway Trust Management Limited, the Manager of PLife REIT.

Since its initial public offering in 2007, Mr. Yong has led the REIT to more than double its asset portfolio value. He was instrumental in ensuring that the REIT consistently delivers value to Unitholders, with Distributions Per Unit growing 133.7% since its IPO and the inclusion of PLife REIT in major indexes further affirming its strong position as one of the largest listed healthcare REITs in Asia.

In 2023, PLife REIT clinched the prestigious Singapore Corporate Sustainability Award 2023 [REITs & Business Trusts Category] at the SIAS Investors’ Choice Awards Presentation Ceremony which is supported by the Singapore Exchange and endorsed by esteemed industry organisations and institutions.

The award recognises the REIT’s comprehensive performance in environmental, social, and governance (ESG) aspects of sustainability disclosures and reporting, reflecting its holistic approach towards sustainability. Importantly, the award validates and recognises the REIT’s risk approach to ESG that has led to PLife REIT’s strong market positioning to enhance Unitholder value and transparency in assuring Unitholders of the long-term financial viability and strengths of the Group.

Mr. Yong’s deep expertise in finance and corporate strategy is attributed to his prior work experience as the CFO of the Singapore Tourism Board, overseeing its finance and corporate services functions. Prior to that, he was the CFO of Ascendas Pte Ltd (Ascendas). During his tenure with Ascendas, he was seconded to China-Singapore Suzhou Development Ltd and Singapore-Suzhou Township Development Pte Ltd as their CFO in Suzhou, China. Before joining Ascendas, Mr. Yong held other finance and audit positions at Beijing ISS International School, Housing and Development Board and Arthur Andersen.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• B.ACC (Hons), Fellow Chartered Accountant of Singapore
• Advanced Management Programme with Harvard Business School

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Independent Director and Audit & Risk Committee Chairman of China-Singapore Suzhou Industrial Park Development Group Co., Ltd

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Nil